@novonordisk Over the past few years, shareholders have all been dying. Please do something for us. We are having a very hard time.. please please save us. save us.. save.. us
$HIMS is now promoting real Wegovy from $NVO.
Wegovy (pills + injections) and Ozempic will be offered at cash-pay prices starting from $149/month.
A clear shift away from compounded GLP-1s toward branded drugs.
Novoβs distribution is evolving fast and access is expanding rapidly.
Link to press release: https://t.co/5B8IfxiIN1
#stocks #Investing
@novonordisk Hims even rebounded, but Nvo, which made the best oral obesity treatment in existence, is the lowest ever. Everything is good, but please save the shareholders.